Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baris Akinci

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
The New England Journal of Medicine|May 9, 2019
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesBaris Akinci
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|July 26, 2012
Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders: an updateBaris Akinci
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|November 12, 2015
Metreleptin Treatment in Patients with Non-HIV Associated LipodystrophyGulcin Akinci, Baris Akinci
Presse Medicale (Paris, France : 1983)|November 3, 2021
Complications of lipodystrophy syndromesGulcin Akinci, Merve Celik, Baris Akinci
Current Diabetes Reports|November 9, 2018
Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and ComorbiditiesBaris Akinci, Rasimcan Meral, Elif Arioglu Oral
Current Diabetes Reports|October 30, 2018
Update on Therapeutic Options in LipodystrophyBaris Akinci, Rasimcan Meral, Elif Arioglu Oral
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|November 15, 2011
The alteration of coagulation in patients with thyroid dysfunctionBaris Akinci, Abdurrahman Comlekci, Mehmet A Ozcan
Acta Diabetologica|December 10, 2025
Metabolic effects of pioglitazone and sodium-glucose cotransporter 2 inhibitors in familial partial lipodystrophyUtku Soyaltin, Ilgin Y Simsir, Baris Akinci
Fertility and Sterility|January 17, 2009
Prediction of developing metabolic syndrome after gestational diabetes mellitusBaris Akinci, Aygul Celtik, Serkan Yener, et al.
Diabetes Research and Clinical Practice|September 5, 2008
Is fasting glucose level during oral glucose tolerance test an indicator of the insulin need in gestational diabetes?Baris Akinci, Aygul Celtik, Serkan Yener, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|May 9, 2019
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesBaris Akinci
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|July 26, 2012
Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders: an updateBaris Akinci
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|November 12, 2015
Metreleptin Treatment in Patients with Non-HIV Associated LipodystrophyGulcin Akinci, Baris Akinci
Presse Medicale (Paris, France : 1983)|November 3, 2021
Complications of lipodystrophy syndromesGulcin Akinci, Merve Celik, Baris Akinci
Current Diabetes Reports|November 9, 2018
Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and ComorbiditiesBaris Akinci, Rasimcan Meral, Elif Arioglu Oral
Current Diabetes Reports|October 30, 2018
Update on Therapeutic Options in LipodystrophyBaris Akinci, Rasimcan Meral, Elif Arioglu Oral
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery|November 15, 2011
The alteration of coagulation in patients with thyroid dysfunctionBaris Akinci, Abdurrahman Comlekci, Mehmet A Ozcan
Acta Diabetologica|December 10, 2025
Metabolic effects of pioglitazone and sodium-glucose cotransporter 2 inhibitors in familial partial lipodystrophyUtku Soyaltin, Ilgin Y Simsir, Baris Akinci
Fertility and Sterility|January 17, 2009
Prediction of developing metabolic syndrome after gestational diabetes mellitusBaris Akinci, Aygul Celtik, Serkan Yener, et al.
Diabetes Research and Clinical Practice|September 5, 2008
Is fasting glucose level during oral glucose tolerance test an indicator of the insulin need in gestational diabetes?Baris Akinci, Aygul Celtik, Serkan Yener, et al.
Pageof 11